Anti-ErbB-2 MicroBeads can be used for the enrichment of disseminated epithelial ErbB-2-expressing tumor cells from blood, bone marrow, or leukapheresis harvest.

Data and images for Anti-ErbB-2 MicroBeads, human

Figures

Figure 1

View details
A cluster of cytokeratin-positive cells isolated with Anti-ErbB-2 MicroBeads from peripheral blood of a patient with primary breast cancer. Cells were stained following the in-column intracellular staining protocol using the Inside Stain Kit in combination with Anti-Cytokeratin-Alkaline Phosphatase.

Figure 1

A cluster of cytokeratin-positive cells isolated with Anti-ErbB-2 MicroBeads from peripheral blood of a patient with primary breast cancer. Cells were stained following the in-column intracellular staining protocol using the Inside Stain Kit in combination with Anti-Cytokeratin-Alkaline Phosphatase.

Specifications for Anti-ErbB-2 MicroBeads, human

Overview

Anti-ErbB-2 MicroBeads can be used for the enrichment of disseminated epithelial ErbB-2-expressing tumor cells from blood, bone marrow, or leukapheresis harvest.

Detailed product information

Background information

ErbB-2, also known as HER2/neu, CD340 or p185, encodes the human epidermal growth factor receptor which is overexpressed in 25–30% of breast cancer patients as well as in various other tumors, e.g. ovarian, prostate, lung, colorectal, pancreatic, and gastric cancers.

Downstream applications

Enriched ErbB-2
+
cells can be characterized by using different techniques such as quantitative real-time PCR
1
, immunocytochemistry, or flow cytometry. The enriched cells can also be cultured.

Columns

MS, LS, XS, or autoMACS
®
Columns.

Resources for Anti-ErbB-2 MicroBeads, human

Documents and Protocols

References for Anti-ErbB-2 MicroBeads, human

Publications

  1. Molloy, T. J. et al. (2008) Towards an optimized platform for the detection, enrichment, and semi-quantitation circulating tumor cells. Breast Cancer Res. Treat. 112: 297-307

Related products for
Anti-ErbB-2 MicroBeads, human

6 products available | view all